TABLE 3.
Substrate and inhibitor profiles of purified CTX-M-5 β-lactamase
| Substrate or inhibitor | kcat (s−1) | Relative kcat | Km (μM) | kcat/Km (mM−1s−1) | IC50 (nM) |
|---|---|---|---|---|---|
| Substrates | |||||
| Benzylpenicillin | 230 | 100 | 50 | 4,600 | |
| Cephaloridine | 1,500 | 680 | 350 | 4,400 | |
| Cefotaxime | 210 | 95 | 77 | 2,800 | |
| Ceftazidime | 7.4 | 3.3 | 440 | 17 | |
| Aztreonam | 21 | 9.3 | 730 | 29 | |
| Cefoxitin | 0.41 | 0.18 | NCa | NC | |
| Imipenem | 0.0027 | 0.0012 | NC | NC | |
| Inhibitors | |||||
| Clavulanic Acid | 19 | ||||
| Sulbactam | 100 | ||||
| Tazobactam | 3.3 |
NC, not calculated (rates were too low to obtain reliable values).